Gastrointestinal Cancers Articles & Analysis
6 articles found
ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients with metastatic cancers in 20201. At that time, based ...
Further complexity arises as cancer cells also express the adenosine A1 receptor (ADORA1) and A3 receptor (ADORA3). ...
Introduction Genomics has revolutionized cancer research, transforming the way we diagnose, treat, and monitor cancer. ...
There are also studies showing that through the use of bromelain, the metastasis of cancer cells can be stopped or slowed down, which can have a positive impact on cancer treatment. In a study conducted in 2013, scientists observed that bromelain had a direct effect on the growth and spread of gastrointestinal cancer cells, with ...
Subjects who met any of the following criteria were excluded: (1) hepatitis B or C virus infection; (2) autoimmune hepatitis, primary biliary cholangitis or primary sclerosing cholangitis; (3) gastrointestinal cancers or hepatocellular carcinoma; (4) drug-induced steatosis or liver injury; (5) Wilson disease or hemochromatosis; (6) excessive alcohol consumption ...
Testing a patient’s breath to monitor a variety of issues, including asthma, gastrointestinal issues and cancer, is often less invasive and less expensive than other types of tests. ...